NORWALK, Conn.--(BUSINESS WIRE)--The Multiple Myeloma Research Consortium (MMRC) today announced the presentation of studies conducted through its clinical sites in collaboration with industry partners, Onyx Pharmaceuticals and Bristol-Myers Squibb, in evaluating promising new therapeutic agents for multiple myeloma at the 46th Annual American Society of Clinical Oncology (ASCO) Meeting, June 4-8, 2010 in Chicago, IL. The oral presentations will include updated data on MMRC-associated studies of potential drugs in the treatment of multiple myeloma.
